Correlation Between Summa Silver and Rakovina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Summa Silver and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summa Silver and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summa Silver Corp and Rakovina Therapeutics, you can compare the effects of market volatilities on Summa Silver and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summa Silver with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summa Silver and Rakovina Therapeutics.

Diversification Opportunities for Summa Silver and Rakovina Therapeutics

0.65

Correlation Coefficient

Summa Silver  Rakovina Therapeutics

Poor diversification

The 3 months correlation between Summa and Rakovina is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Summa Silver Corp and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Summa Silver is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summa Silver Corp are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Summa Silver i.e., Summa Silver and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between Summa Silver and Rakovina Therapeutics

Assuming the 90 days trading horizon Summa Silver Corp is expected to generate 0.58 times more return on investment than Rakovina Therapeutics. However, Summa Silver Corp is 1.71 times less risky than Rakovina Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  28.00  in Summa Silver Corp on April 24, 2025 and sell it today you would earn a total of  21.00  from holding Summa Silver Corp or generate 75.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Summa Silver Corp  vs.  Rakovina Therapeutics

Summa Silver Corp

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Summa Silver Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Summa Silver showed solid returns over the last few months and may actually be approaching a breakup point.

Rakovina Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Summa Silver and Rakovina Therapeutics

The main advantage of trading using opposite Summa Silver and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summa Silver position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.

The idea behind Summa Silver Corp and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.